INFINITY PHARMACEUTICALS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$697.2M

727 transactions

Summary

INFINITY PHARMACEUTICALS, INC. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $206.5MSales: $487.0M59 insiders

Date	Insider	Type	Value
2022-06-16	EVNIN ANTHONY B	A	$32K
2023-09-12	Perkins Adelene Q	Sell	$29K
2022-06-16	SCHWARTZ BRIAN	A	$21K
2022-08-02	Peluso Stephane(Chief Scientific Officer)	Sell	$10K
2023-09-09	Perkins Adelene Q	M	$0
2023-09-09	Perkins Adelene Q	M	—
2022-08-02	Peluso Stephane(Chief Scientific Officer)	M	$0
2022-08-02	Peluso Stephane(Chief Scientific Officer)	M	—
2022-06-16	SCHWARTZ BRIAN	A	$0
2022-06-16	SELBY NORMAN C	A	$0
2022-06-16	SELBY NORMAN C	A	$0
2022-06-16	Agresta Samuel	A	$0
2022-06-16	GAYNOR RICHARD	A	$0
2022-06-16	BEIER DAVID W	A	$0
2022-06-16	EVNIN ANTHONY B	A	$0
2022-03-30	KANGO SUJAY	A	$0
2022-01-11	Ilaria Robert Jr.(Chief Medical Officer)	A	$0
2022-01-11	Peluso Stephane(Chief Scientific Officer)	A	$0
2022-01-11	Tasker Seth A(Chief Business Officer)	A	$0
2022-01-11	BLOCH LAWRENCE E(President)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

INFINITY PHARMACEUTICALS, INC. — Contributions, Lobbying & Contracts | Poliscope